Evidence map›Paper›PMID 26996206›Full record

ArticleScientific reports2016

The antimicrobial polymer PHMB enters cells and selectively condenses bacterial chromosomes.

Kantaraja Chindera, Manohar Mahato, Ashwani Kumar Sharma, Harry Horsley, Klaudia Kloc-Muniak, Nor Fadhilah Kamaruzzaman, Satish Kumar, Alexander McFarlane, Jem Stach, Thomas Bentin and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed
15.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 248 citations in OpenAlex.

  1. Article
  2. Review
  3. When Disinfection Fails: Biocide Tolerance as a Driver ofAntibiotics (Basel, Switzerland) · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Molecular mechanisms of disinfectant resistance inJAC-antimicrobial resistance · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 4 countries.

Kantaraja ChinderaDepartment of Pathology and Pathogen Biology, Royal Veterinary College, University of London, Royal College Street, London, NW1 0TU, UK.
Manohar MahatoNucleic Acids Research Laboratory, CSIR-Institute of Genomics and Integrative Biology, Mall Road, Delhi-110 007, India.
Ashwani Kumar SharmaNucleic Acids Research Laboratory, CSIR-Institute of Genomics and Integrative Biology, Mall Road, Delhi-110 007, India.
Harry HorsleyCentre for Clinical Science &Technology, University College London, Wolfson House, 2-10 Stephenson Way, London NW1 2HE, UK.
Klaudia Kloc-MuniakTecrea Ltd, London Bioscience Innovation Centre, 2 Royal College Street, London, NW1 0NH, UK.
Nor Fadhilah KamaruzzamanDepartment of Pathology and Pathogen Biology, Royal Veterinary College, University of London, Royal College Street, London, NW1 0TU, UK.
Satish KumarDivision of Animal Biotechnology, Indian Veterinary Research Institute, Izatnagar, Bareilly, Uttar Pradesh, 243 122, India.
Alexander McFarlaneSchool of Biology, University of Newcastle, Newcastle upon Tyne, NE1 7RU, UK.
Jem StachSchool of Biology, University of Newcastle, Newcastle upon Tyne, NE1 7RU, UK.
Thomas BentinDepartment of Cellular and Molecular Medicine, University of Copenhagen, Blegdamsvej 3C, 2200 Copenhagen N, Denmark.
Liam GoodDepartment of Pathology and Pathogen Biology, Royal Veterinary College, University of London, Royal College Street, London, NW1 0TU, UK.
Royal Veterinary College · GBInstitute of Genomics and Integrative Biology · INNewcastle University · GBIndian Veterinary Research Institute · INTecrea (United Kingdom) · GBUniversity College London · GBUniversity of Copenhagen · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To combat infection and antimicrobial resistance, it is helpful to elucidate drug mechanism(s) of action. Here we examined how the widely used antimicrobial polyhexamethylene biguanide (PHMB) kills bacteria selectively over host cells. Contrary to the accepted model of microbial membrane disruption by PHMB, we observed cell entry into a range of bacterial species, and treated bacteria displayed cell division arrest and chromosome condensation, suggesting DNA binding as an alternative antimicrobial mechanism. A DNA-level mechanism was confirmed by observations that PHMB formed nanoparticles when mixed with isolated bacterial chromosomal DNA and its effects on growth were suppressed by pairwise combination with the DNA binding ligand Hoechst 33258. PHMB also entered mammalian cells, but was trapped within endosomes and excluded from nuclei. Therefore, PHMB displays differential access to bacterial and mammalian cellular DNA and selectively binds and condenses bacterial chromosomes. Because acquired resistance to PHMB has not been reported, selective chromosome condensation provides an unanticipated paradigm for antimicrobial action that may not succumb to resistance.

Indexed as

AnimalsAnti-Bacterial AgentsBacillus megateriumBiguanidesCattleCell Membrane PermeabilityCHO CellsChromosomes, BacterialChromosome StructuresCricetinaeCricetulusEscherichia coliHEK293 CellsHeLa CellsHorsesHumansAnti-Bacterial AgentsBiguanidespolihexanide

Identifiers

PMID26996206
PMCPMC4800398
OpenAlexW2314772000

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.